74 related articles for article (PubMed ID: 2407943)
1. [Pathobiology of human primary benign and malignant liver tumors].
Schaff Z; Jeney A; Kopper L; Kovalszky I; Karácsonyi S; Szécsény A; Lapis K
Morphol Igazsagugyi Orv Sz; 1990 Jan; 30(1):18-27. PubMed ID: 2407943
[TBL] [Abstract][Full Text] [Related]
2. [Focal nodular hyperplasia and liver cell adenoma: operation or observation?].
Ott R; Hohenberger W
Zentralbl Chir; 1998; 123(2):145-53. PubMed ID: 9556887
[TBL] [Abstract][Full Text] [Related]
3. Distinction of hepatocellular carcinoma from benign hepatic mimickers using Glypican-3 and CD34 immunohistochemistry.
Coston WM; Loera S; Lau SK; Ishizawa S; Jiang Z; Wu CL; Yen Y; Weiss LM; Chu PG
Am J Surg Pathol; 2008 Mar; 32(3):433-44. PubMed ID: 18300806
[TBL] [Abstract][Full Text] [Related]
4. Flow cytometric analysis of DNA content in focal nodular hyperplasia and hepatocellular carcinoma.
Kopper L; Lapis K; Schaff Z; Mihalik R; Karácsony S; Szécsény A
Neoplasma; 1991; 38(3):257-63. PubMed ID: 1649974
[TBL] [Abstract][Full Text] [Related]
5. Molecular pathogenesis of focal nodular hyperplasia and hepatocellular adenoma.
Rebouissou S; Bioulac-Sage P; Zucman-Rossi J
J Hepatol; 2008 Jan; 48(1):163-70. PubMed ID: 17997499
[TBL] [Abstract][Full Text] [Related]
6. Connective tissue content of fibrolamellar carcinoma and other human liver tumors.
Sárosi I; Kiss A; Schaff Z; Lapis K
Acta Microbiol Hung; 1991; 39(4):321-31. PubMed ID: 1668900
[TBL] [Abstract][Full Text] [Related]
7. Connective tissue content of fibrolamellar carcinoma and other human liver tumors.
Sárosi I; Kiss A; Schaff Z; Lapis K
Acta Morphol Hung; 1991; 39(4):321-31. PubMed ID: 1668901
[TBL] [Abstract][Full Text] [Related]
8. Expression of xenobiotic and steroid hormone metabolizing enzymes in hepatocellular tumors of the non-cirrhotic liver.
Haas S; Merkelbach-Bruse S; Justenhoven C; Brauch H; Fischer HP
Pathol Res Pract; 2009; 205(10):716-25. PubMed ID: 19596526
[TBL] [Abstract][Full Text] [Related]
9. Transforming growth factor beta 1 in human liver tumors.
Vogelbruch M; Wellmann A; Maschek H; Schäfer MK; Flemming P; Georgii A
Verh Dtsch Ges Pathol; 1995; 79():132-6. PubMed ID: 8600677
[TBL] [Abstract][Full Text] [Related]
10. Benign and solid tumors of the liver: relationship to sex, age, size of tumors, and outcome.
Reddy KR; Kligerman S; Levi J; Livingstone A; Molina E; Franceschi D; Badalamenti S; Jeffers L; Tzakis A; Schiff ER
Am Surg; 2001 Feb; 67(2):173-8. PubMed ID: 11243545
[TBL] [Abstract][Full Text] [Related]
11. Chromosomal analysis of hepatic adenoma and focal nodular hyperplasia by comparative genomic hybridization.
Chen YJ; Chen PJ; Lee MC; Yeh SH; Hsu MT; Lin CH
Genes Chromosomes Cancer; 2002 Oct; 35(2):138-43. PubMed ID: 12203777
[TBL] [Abstract][Full Text] [Related]
12. Multiple spontaneous liver cell adenomas of different types (liver adenomatosis).
Bisceglia M; Gatta A; Tomezzoli A; Donataccio M
Adv Anat Pathol; 2009 May; 16(3):172-9. PubMed ID: 19395881
[TBL] [Abstract][Full Text] [Related]
13. Significance of cellular DNA content in human liver tumors.
Kopper L; Lapis K; Schaff Z; Mihalik R
Acta Biomed Ateneo Parmense; 1993; 64(5-6):165-9. PubMed ID: 7992554
[TBL] [Abstract][Full Text] [Related]
14. Evidence for the polyclonal nature of focal nodular hyperplasia of the liver by the study of X-chromosome inactivation.
Paradis V; Laurent A; Flejou JF; Vidaud M; Bedossa P
Hepatology; 1997 Oct; 26(4):891-5. PubMed ID: 9328310
[TBL] [Abstract][Full Text] [Related]
15. Retrospective analysis of 29 patients surgically treated for hepatocellular adenoma or focal nodular hyperplasia.
Closset J; Veys I; Peny MO; Braude P; Van Gansbeke D; Lambilliotte JP; Gelin M
Hepatogastroenterology; 2000; 47(35):1382-4. PubMed ID: 11100357
[TBL] [Abstract][Full Text] [Related]
16. [Surgery of benign liver tumors].
Ringe B; Mauz S; Barg-Hock H; Kotzerke J; Pichlmayr R
Langenbecks Arch Chir Suppl II Verh Dtsch Ges Chir; 1989; ():287-91. PubMed ID: 2577558
[TBL] [Abstract][Full Text] [Related]
17. [The therapeutic strategy in benign liver tumors: a 20-year experience].
Mangiante G; Nicoli N; Marchiori L; Procacci C; Giorgetti ; Colombari R; Aurola PP; Serio G
Chir Ital; 1994; 46(1):50-60. PubMed ID: 8025971
[TBL] [Abstract][Full Text] [Related]
18. Flow cytometric DNA analysis of cirrhotic liver cells in patients with hepatocellular carcinoma can provide a new prognostic factor.
Ruà S; Comino A; Fruttero A; Torchio P; Bouzari H; Taraglio S; Torchio B; Capussotti L
Cancer; 1996 Sep; 78(6):1195-202. PubMed ID: 8826940
[TBL] [Abstract][Full Text] [Related]
19. Flow cytometric DNA-ploidy and proliferative activity of diethylnitrosamine-induced hepatocellular carcinoma and pulmonary metastases in monkeys.
Lapis K; Bocsi J; Lapis P; Thorgeirsson UP
Hepatology; 1995 Sep; 22(3):952-61. PubMed ID: 7657303
[TBL] [Abstract][Full Text] [Related]
20. Steroid related neoplasia in human liver.
Barrows GH; Mays ET; Christopherson WM
Princess Takamatsu Symp; 1987; 18():47-59. PubMed ID: 2852190
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
